TY - JOUR
T1 - Measuring quality of life and patient satisfaction after body contouring
T2 - A systematic review of patient-reported outcome measures
AU - Reavey, Patrick L.
AU - Klassen, Anne F.
AU - Cano, Stefan J.
AU - McCarthy, Colleen
AU - Scott, Amie
AU - Peter Rubin, J.
AU - Shermak, Michele
AU - Pusic, Andrea L.
PY - 2011/9
Y1 - 2011/9
N2 - Evidence-Based Background: In both cosmetic and postbariatric body contouring populations, the primary determinants of success are patient satisfaction and quality of life (QOL). These patient-reported outcomes (PRO) are ideally measured with specially-designed, procedure-or conditionspecific questionnaires. Objective: The authors identify and appraise all patient-reported outcome (PRO) measures (questionnaires) developed for patients undergoing body contouring surgery. Methods: MEDLINE, EMBASE, PsychINFO, Ebase, CINAHL, HAPI, Science Citation Index/Social Sciences Citation Index, Ovid Evidence Based Medicine databases were searched from the inception of each database through August 2010. Articles included in the study described the development and/or psychometric evaluation of a PRO measure developed for body contouring patients. Each measure was then appraised for adherence to internationallyrecommended guidelines for item generation, item reduction, and psychometric evaluation. Results: The following five PRO questionnaires were identified by our search: one liposuction (the Freiburg Questionnaire on Aesthetic Dermatology and Cosmetic Surgery, FQAD), one general plastic surgery (Derriford Appearance Scale, DAS-59/24), and three breast reduction measures (the Breast Reduction Assessed Severity Scale Questionnaire, BRASSQ; Breast Related Symptoms questionnaire, BRS; and the BREAST-Q reduction module. Detailed examination of these measures revealed that the FQAD, DAS-59, and BRS are limited by both their content range and psychometric properties. The BRASSQ and BREAST-Q both have strong psychometric properties, and the BREAST-Q is unique in its inclusion of items covering specific postoperative issues such as scarring. Conclusions: While instruments are available for measuring outcomes in breast reduction patients, reliable, valid, and responsive PRO measures are lacking for the majority of body contouring procedures. To demonstrate the unique outcomes of body contouring surgery, future research to rigorously develop and validate new PRO measures in this population is necessary.
AB - Evidence-Based Background: In both cosmetic and postbariatric body contouring populations, the primary determinants of success are patient satisfaction and quality of life (QOL). These patient-reported outcomes (PRO) are ideally measured with specially-designed, procedure-or conditionspecific questionnaires. Objective: The authors identify and appraise all patient-reported outcome (PRO) measures (questionnaires) developed for patients undergoing body contouring surgery. Methods: MEDLINE, EMBASE, PsychINFO, Ebase, CINAHL, HAPI, Science Citation Index/Social Sciences Citation Index, Ovid Evidence Based Medicine databases were searched from the inception of each database through August 2010. Articles included in the study described the development and/or psychometric evaluation of a PRO measure developed for body contouring patients. Each measure was then appraised for adherence to internationallyrecommended guidelines for item generation, item reduction, and psychometric evaluation. Results: The following five PRO questionnaires were identified by our search: one liposuction (the Freiburg Questionnaire on Aesthetic Dermatology and Cosmetic Surgery, FQAD), one general plastic surgery (Derriford Appearance Scale, DAS-59/24), and three breast reduction measures (the Breast Reduction Assessed Severity Scale Questionnaire, BRASSQ; Breast Related Symptoms questionnaire, BRS; and the BREAST-Q reduction module. Detailed examination of these measures revealed that the FQAD, DAS-59, and BRS are limited by both their content range and psychometric properties. The BRASSQ and BREAST-Q both have strong psychometric properties, and the BREAST-Q is unique in its inclusion of items covering specific postoperative issues such as scarring. Conclusions: While instruments are available for measuring outcomes in breast reduction patients, reliable, valid, and responsive PRO measures are lacking for the majority of body contouring procedures. To demonstrate the unique outcomes of body contouring surgery, future research to rigorously develop and validate new PRO measures in this population is necessary.
KW - Abdominoplasty
KW - Body contouring
KW - Brachioplasty
KW - Breast reduction
KW - Dermatolipectomy
KW - Liposuction
KW - Massive weight loss
KW - Obesity
KW - Thighplasty
UR - http://www.scopus.com/inward/record.url?scp=84855739714&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84855739714&partnerID=8YFLogxK
U2 - 10.1177/1090820X11417426
DO - 10.1177/1090820X11417426
M3 - Review article
C2 - 21908812
AN - SCOPUS:84855739714
SN - 1090-820X
VL - 31
SP - 807
EP - 813
JO - Aesthetic Surgery Journal
JF - Aesthetic Surgery Journal
IS - 7
ER -